Association of High Body Mass Index with Response Outcomes in Patients with CML-CP Treated with Dasatinib Versus Imatinib in the First Line: Exploratory Post Hoc Analysis of the Phase 3 DASISION Trial
In: Blood, Jg. 134 (2019-11-13), Heft Supplement 1, S. 4155
academicJournal
Zugriff:
Titel: |
Association of High Body Mass Index with Response Outcomes in Patients with CML-CP Treated with Dasatinib Versus Imatinib in the First Line: Exploratory Post Hoc Analysis of the Phase 3 DASISION Trial
|
---|---|
Autor/in / Beteiligte Person: | Breccia, Massimo ; Cortes, Jorge E. ; Shah, Neil P ; Saglio, Giuseppe ; Jiménez-Velasco, Antonio ; Le Coutre, Philipp ; Brun, Alexander ; DeGutis, Irene ; Bathena, Sai ; Sy, Oumar ; Jabbour, Elias |
Zeitschrift: | Blood, Jg. 134 (2019-11-13), Heft Supplement 1, S. 4155 |
Veröffentlichung: | 2019 |
Medientyp: | academicJournal |
ISSN: | 0006-4971 (electronic) |
DOI: | 10.1182/blood-2019-121872 |
Sonstiges: |
|